Transnational cancer research lab | Felsenstein Medical Research Center
PLOS ONE: The Impact of Bevacizumab (Avastin) on Survival in Metastatic Solid Tumors - A Meta-Analysis and Systematic Review
Team - ADM Capital
Salomon Undhof — Vintage and Vine
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology
Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer | NEJM
Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE) - Annals of Oncology
Can-Fite Initiates Compassionate Use Program for Namodenoson in the Treatment of Liver Cancer, Enrolls and Treats Patients | Business Wire
Our Team – CTG-Pharma
Transnational cancer research lab | Felsenstein Medical Research Center
Faculty | CoBrCa – Controversies in Breast Cancer
OncologyEducation a Twitter: "Dr. Salomon Stemmer provides an update of Namodenoson in patients with Child-Pugh B hepatocellular carcinoma in this video from #ASCO19: https://t.co/82i6FiWc4l https://t.co/SlkSpAAMot" / Twitter
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology
First-of-its-kind study in Israel finds that cancer patients are safe for COVID-19 vaccines - EJP
The Impact of Bevacizumab (Avastin) on Survival in Metastatic Solid Tumors - A Meta-Analysis and Systematic Review
Barak Pertzov (@barakpertzov) / Twitter
Transnational cancer research lab | Felsenstein Medical Research Center
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology
Can-Fite: Progress in Compassionate Use Program Treating Advanced Liver Cancer Patients with Namodenoson | Business Wire
Menendez co-defendant sentenced to 17 years in separate case | CNN Politics
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology
UT Southwestern Radiation Oncology - Congratulations to Dr. Prasanna Alluri, Assistant Professor of Radiation Oncology at UT Southwestern, and Dr. Salomon Stemmer, Professor in Oncology at Rabin Medical Center, for being awarded
First-of-its-kind study in Israel finds that cancer patients are safe for COVID-19 vaccines - EJP
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology
